Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
225 studies found for:    Open Studies | "Heparin"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Unknown † Efficacy And Safety Of Unfractionated Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary Bypass
Condition: Prevention of Venous Thromboembolism
Interventions: Biological: bovine heparin;   Biological: Porcine heparin
22 Recruiting Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection
Conditions: Kidney Failure, Chronic;   Catheter-Related Infections
Interventions: Drug: Neutrolin;   Drug: Heparin
23 Unknown † Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis
Condition: Deep Venous Thrombosis
Intervention: Drug: Low-Molecular-Weight Heparin
24 Unknown † Efficacy And Safety Of Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary Bypass
Condition: Prevention of Venous Thromboembolism
Interventions: Biological: Bovine Heparin;   Biological: Porcine heparin
25 Unknown † Comparison of Slow Efficiency Daily Dialysis (SLEDD) With Unfractionated Heparin Versus Citrasate in Critically Ill Patients.
Conditions: Acute Kidney Injury;   Hemodialysis
Interventions: Drug: Unfractionated heparin;   Drug: Citrasate
26 Unknown † Citrate Versus Heparin Anticoagulation: Effect on Molecules Clearances
Condition: Septic Shock
Interventions: Drug: Anticoagulation to prevent clotting of the extracorporeal circuit. (regional citrate anticoagulation);   Drug: Anticoagulation to prevent clotting of the extracorporeal circuit (Unfractionated heparin)
27 Recruiting The Efficacy of Extract of Allium Cepae, Allantoin and Heparin in Patients With Proven Scar Development
Condition: Cicatrix
Interventions: Drug: extract of allium cepae, allantoin and heparin;   Procedure: Scar excision
28 Unknown † PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (INTRAVENOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS
Condition: Healthy
Intervention: Drug: Heparin
29 Unknown † CATCH - Catheter Infections in Children
Condition: Catheter-Related Infections
Interventions: Device: Standard polyurethane Central Venous Catheter;   Device: Antibiotic impregnated polyurethane CVC (minocycline and rifampicin);   Device: Heparin bonded polyurethane CVC
30 Unknown † PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (SUBCUTANEOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS
Condition: Healthy
Intervention: Drug: Heparin
31 Recruiting Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome
Conditions: Acute Chest Syndrome;   Sickle Cell Disease
Intervention: Drug: Unfractionated heparin
32 Recruiting Predictive Factors of Intestinal Infraction in Acute Mesenteric Ischemia
Condition: Mesenteric Ischemia
Intervention: Drug: Heparin injection
33 Unknown † Study of Blood Clotting After Transcatheter Atrial Septal Defect Closure
Condition: Thrombosis
Intervention: Drug: Low molecular weight heparin
34 Recruiting Heparin Based on Ideal Body Weight for Cardiopulmonary Bypass in Obese Patients
Conditions: Cardiac Surgery;   Cardiopulmonary Bypass;   Obese Patients (BMI ≥ 30 kg/m²)
Interventions: Drug: Heparin, IV route, based on patients body weights (UI/kg);   Procedure: Cardiopulmonary bypass;   Drug: Protamin administration
35 Recruiting Role of Heparin in Poor Responders Undergoing In Vitro Fertilisation
Condition: Infertility
Interventions: Drug: Heparin, Low-Molecular-Weight;   Drug: no heparin
36 Not yet recruiting Bivalirudin in Acute Myocardial Infarction
Condition: Acute Myocardial Infarction
Interventions: Drug: Bivalirudin;   Drug: heparin
37 Unknown † Platelet Function With New Pediatric Oxygenator and Heparin and Non Heparin Coating in Pediatric Cardiac Surgery
Condition: Acquired Platelet Function Disorder
Intervention: Device: Balance surface, Carmeda heparin-coated surface
38 Recruiting Evaluation of the Heparin Binding Protein Levels in Sepsis
Conditions: Sepsis;   Infection;   Septic Shock
Intervention: Other: HBP lab test
39 Not yet recruiting Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.
Conditions: Rhegmatogenous Retinal Detachment;   High-risk for Proliferative Vitreoretinopathy (PVR)
Interventions: Drug: 5-fluorouracil and low molecular weight heparin;   Drug: Placebo
40 Unknown † Citrate Versus Heparin for the Lock of Non-tunneled Hemodialysis Catheters in Patients Hospitalised in ICU
Condition: Patients With Acute Renal Insufficiency
Interventions: Drug: Citrate 4%;   Drug: unfractionated heparin
To Top

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
† Indicates status has not been verified in more than two years